TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
POA Pharma Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
9,178
|
8,293
|
7,768 |
| Financial expenses |
83
|
16
|
2 |
| Earnings before taxes |
-66
|
129
|
361 |
| EBITDA |
58
|
216
|
446 |
| Total assets |
4,923
|
4,595
|
3,737 |
| Current assets |
4,790
|
4,395
|
3,505 |
| Current liabilities |
2,608
|
2,235
|
1,300 |
| Equity capital |
2,315
|
2,360
|
2,437 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
13
|
13
|
12 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
47.0%
|
51.4%
|
65.2% |
| Turnover per employee |
706
|
638
|
647 |
| Profit as a percentage of turnover |
-0.7%
|
1.6%
|
4.6% |
| Return on assets (ROA) |
0.3%
|
3.2%
|
9.7% |
| Current ratio |
183.7%
|
196.6%
|
269.6% |
| Return on equity (ROE) |
-2.9%
|
5.5%
|
14.8% |
| Change turnover |
743
|
914
|
560 |
| Change turnover % |
9%
|
12%
|
8% |
| Chg. No. of employees |
0
|
1
|
-2 |
| Chg. No. of employees % |
0%
|
8%
|
-14% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.